Globus Medical GMED Emerging Technology — Revenue
Discontinued — last reported Q3 '25
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Globus Medical’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's emerging technology — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Globus Medical's emerging technology — revenue?
- Globus Medical (GMED) reported emerging technology — revenue of $28.04M in Q3 2025.
- How has Globus Medical's emerging technology — revenue changed year-over-year?
- Globus Medical's emerging technology — revenue decreased by 26.8% year-over-year, from $38.3M to $28.04M.
- What is the long-term trend for Globus Medical's emerging technology — revenue?
- Over 3 years (2021 to 2024), Globus Medical's emerging technology — revenue has grown at a 23.7% compound annual growth rate (CAGR), from $81.32M to $154M.
- What does emerging technology — revenue mean?
- Total revenue generated from the company's advanced surgical robotics and digital technology product segment.
- How do you interpret emerging technology — revenue?
- An increase suggests strong market penetration and adoption of the company's advanced surgical platforms, while a decrease may indicate market saturation or increased competition in the robotic surgery space.
- How does emerging technology — revenue compare across companies?
- Comparable to robotic-assisted surgery revenue or digital health platform sales reported by other medical device manufacturers in the orthopedic and neurosurgical sectors.